Article Information
History
- March 24, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ariel Israel, M.D., Ph.D.1,2,*,
- Alejandro A Schäffer, Ph.D.3,
- Matitiahu Berkovitch, M.D.4,
- David J. Ozeri, M.D.1,5,
- Eugene Merzon, M.D.1,6,
- Ilan Green, M.D.1,2,
- Avivit Golan-Cohen, M.D.1,2,
- Eytan Ruppin3,
- Shlomo Vinker, M.D.1,2 and
- Eli Magen, M.D.1,7
- 1Leumit Research Institute, Leumit Health Services, Tel Aviv-Yafo 6473817, Israel
- 2Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo 6997801 Israel
- 3Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD 20892, USA
- 4Clinical Pharmacology and Toxicology Unit, Shamir Medical Center, Zerifin
- 5Division of Rheumatology, Sheba Medical Center
- 6Adelson School of Medicine, Ariel University, Ariel 4070000, Israel
- 7Medicine A Department, Assuta Ashdod University Hospital Faculty of Health Sciences, Ben-Gurion University, Beer-Sheba 8410501, Israel
- ↵*The mailing address and phone number for the corresponding author: Ariel Israel, M.D., Ph.D., Director of Leumit Research Institute, Leumit Health Services, Tel-Aviv, Israel, E-mail address: aisrael{at}leumit.co.il
Conflict of interest: The authors have no conflicts of interest to declare pertaining to this article.
Posted March 24, 2023.
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Long-Term Risk of Immune-Related diseases
